A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

Status:
Completed

Trial end date:
2020-02-13

Target enrollment:

Participant gender:

The purpose of this study is to investigate BMS-986165 in participants with different levels of kidney function.

Phase 1

Bristol-Myers Squibb

BMS-986165